CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
12 hedge funds and large institutions have $1.03M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$151K | |
| 2 | -$20.3K | |
| 3 | -$13.8K | |
| 4 |
Focus Partners Wealth
Boston,
Massachusetts
|
-$4.26K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.77K |